Document:

Unassociated Document

Exhibit 10.2.7

Nonstatutory Stock Option

Granted Under the SeraCare Life Sciences, Inc. 2009 Equity Incentive Plan

	
1.  

	
Grant of Option.

 

This certificate evidences a nonstatutory stock option (this “Stock Option”) granted by SeraCare Life Sciences, Inc., a Delaware corporation (the “Company”), on November 18, 2009 to [____________] (the “Participant”) pursuant to the Company’s 2009 Equity Incentive Plan (as from time to time in effect, the “Plan”).  Under this Stock Option, the Participant may purchase, in whole or in part, on the terms herein provided, a total of [___] shares of common stock of the Company (the “Shares”) at $[___]  per Share, subject to adjustment in accordance with the Plan.  The latest date on which this Stock Option, or any part thereof, may be exercised is [__           _] (the “Final Exercise Date”).  The Stock Option evidenced by this certificate is intended to be, and is hereby designated, a nonstatutory option, that is, an option that does not qualify as an incentive stock option as defined in section 422 of the Internal Revenue Code of 1986, as amended from time to time (the “Code”).

 

 

This Stock Option is exercisable in the following cumulative installments prior to the Final Exercise Date:

[_______] Shares on and after [___________________, 20__];

  an additional [_______] Shares on and after [___________________, 20__]; and

  an additional [_______] Shares on and after [___________________, 20__].

Notwithstanding the foregoing, upon termination of the Participant’s Employment, any portion of this Stock Option that is not then exercisable will immediately expire.  Any portion of this Stock Option that is vested and exercisable upon termination of the Participant’s Employment will remain exercisable for three months; provided, that any such portion that is held by the Participant immediately prior to the Participant’s Retirement, Total Disability or death will remain exercisable for one year following the Participant’s Retirement, Total Disability or death; and further provided, that in no event shall any portion of this Stock Option be exercisable after the Final Exercise Date. All portions of this Stock Option will terminate immediately prior to the termination of the Participant’s Employment (or at such earlier time as the Administrator may determine) if termination is determined to be for Cause or in circumstances that the Administrator determines would have justified a termination for Cause.

	
2.  

	
­Exercise of Stock Option.

 

Each election to exercise this Stock Option shall be in writing, signed by the Participant or the Participant’s executor, administrator, or legally appointed representative (in the event of the Participant’s incapacity) or the person or persons to whom this Stock Option is transferred by will or the applicable laws of descent and distribution (collectively, the “Option Holder”), and received by the Company at its principal office, accompanied by this certificate and payment in full as provided in the Plan.  Notwithstanding the foregoing, the Administrator may authorize the exercise of this Option by electronic or paperless means, subject to such rules as the Administrator may establish.  Subject to the further terms and conditions provided in the Plan, the purchase price may be paid as follows:  (i) by delivery of cash or check acceptable to the Administrator; (ii) through a broker-assisted exercise program acceptable to the Administrator; or (iii) through any combination of the foregoing or by such other means of payment, if any, as the Administrator may authorize.  In the event that this Stock Option is exercised by an Option Holder other than the Participant, the Company will be under no obligation to deliver Shares hereunder unless and until it is satisfied as to the authority of the Option Holder to exercise this Stock Option.

 

  

  

  

	
3.  

	
­Restrictions on Transfer of Shares.

 

If at the time this Stock Option is exercised the Company or any of its shareholders is a party to any agreement restricting the transfer of any outstanding shares of the Company’s common stock, the Administrator may provide that this Stock Option may be exercised only if the Shares so acquired are made subject to the transfer restrictions set forth in that agreement (or if more than one such agreement is then in effect, the agreement or agreements specified by the Administrator).

	
4.  

	
­Tax Withholding.

 

If at the time this Stock Option is exercised the Company determines that under applicable law and regulations it could be liable for the withholding of any federal or state tax upon exercise or with respect to a disposition of any Shares acquired upon exercise of this Stock Option, this Stock Option may not be exercised unless the person exercising this Stock Option remits to the Company in cash any amounts determined by the Company to be required to be withheld upon exercise (or makes other arrangements satisfactory to the Company for the payment of such taxes).

	
5.  

	
­Nontransferability of Stock Option.

 

This Stock Option is not transferable by the Participant otherwise than by will or the laws of descent and distribution, and is exercisable during the Participant’s lifetime only by the Participant (or in the event of the Participant’s incapacity, the person or persons legally appointed to act on the Participant’s behalf).

	
6.  

	
­Provisions of the Plan.

 

This Stock Option is subject to the provisions of the Plan, which are incorporated herein by reference.  A copy of the Plan as in effect on the date of the grant of this Stock Option has been furnished to the Participant.  By acknowledging receipt of this certificate and by exercising all or any part of this Stock Option, the Participant agrees to be bound by the terms of the Plan and this certificate.  All initially capitalized terms used herein will have the meaning specified in the Plan, unless another meaning is specified herein.

[Remainder of this page intentionally left blank]

 

  

 

  

 

IN WITNESS WHEREOF, the Company has caused this instrument to be executed by its duly authorized officer.

 

	 	
SeraCare Life Sciences, Inc.

	 
	 	 	 	 
	
 

	
By 

	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

Dated:  [_________________]

 

 

 

	 	
Acknowledged

	 
	 	 	 	 
	
 

	
 

	 	 
	 	 	[Name of Participant]	 
	 	 	 	 
	 	 	 	 

Dated:  [_________________]Unassociated Document

Exhibit 10.3.5

SERACARE LIFE SCIENCES, INC.

 

Fiscal 2012 Director Compensation Program

 

Set forth below are the terms of compensation for members of the Board of Directors (the “Board”) of SeraCare Life Sciences, Inc., a Delaware corporation (the “Company”), as well as the terms of compensation for the various committees of the Board, for the fiscal year beginning October 1, 2011.

 

The Compensation Committee of the Board is providing for the common stock and options to be granted as set forth below to members of the Board under the Company’s 2009 Equity Incentive Plan (the “2009 Plan”), pursuant to the Compensation Committee’s authority under Section 3 of the 2009 Plan to grant and determine the terms of awards under the 2009 Plan.  Any grant shall be subject to the availability of shares under the 2009 Plan for the grant.

 

The number of shares of common stock that shall be granted to any Board member shall be equal in number to (1) the dollar amount of the payment to be made in shares of common stock, divided by (2) the greater of U.S. $1.00 or the closing price per share of the Company’s common stock on the first trading day of the quarter when payment is due (or, in the case of the first quarter of fiscal 2012, the date of adoption of this plan).  The resulting share totals shall be rounded down to the nearest whole share and any fractional amount shall be paid in cash.

 

Payments to Board members for fees for meetings of the Board and committees as provided herein shall not exceed $7,500 in the aggregate per fiscal quarter for all meetings of the Board and committees held during such fiscal quarter.

 

Compensation for Members of the Board

 

·           All Board members (other than Board members who are also employees of the Company) shall receive an annual retainer of $10,000 in cash (pro-rated based on the actual period served) and $10,000 in common stock of the Company (pro-rated based on the actual period served). Such compensation shall be paid quarterly in advance.  Notwithstanding the foregoing, in the event that the shares of common stock of the Company remaining under the 2009 Plan are insufficient to satisfy a grant of common stock described above, then such award shall be paid in cash.

 

·           All Board members (other than Board members who are also employees of the Company) shall receive a five-year option to purchase 15,000 shares of the Company’s common stock at an exercise price equal to the closing price of the Company’s common stock on the date of the grant, such grant to be made at such time as may be determined by the Board.  The Option will have a vesting period of twelve (12) months, which vests quarterly on a pro-rata basis.

 

·           For service as Chair of the Board of Directors, the Chair will receive additional annual compensation of $10,000 in cash (pro-rated based on the actual period served), to be paid quarterly in advance. The Chair will also receive an additional option grant of 10,000 shares, such grant to be made at such time as may be determined by the Board.

 

  

 

  

·           All Board members (other than Board members who are also employees of the Company) shall be reimbursed in cash for their expenses reasonably incurred in serving as Board members and shall also be paid a cash fee of (i) $2,000 for each meeting of the Board of Directors attended in person, and (ii) $500 for each meeting attended telephonically.  Meeting fees will be paid quarterly in arrears.

 

Compensation for Members of the Audit Committee of the Board

 

·           All Audit Committee members other than the Chair of the committee will receive an annual cash fee of $5,000 (pro-rated based on the actual period served), to be paid quarterly in advance.

 

·           The Chair of the Audit Committee shall receive an annual cash fee of $7,500 (pro-rated based on the actual period served), to be paid quarterly in advance.

 

·           All Audit Committee members shall be reimbursed in cash for their expenses reasonably incurred in serving as Audit Committee members and shall also be paid a cash fee of (i) $2,000 for each committee meeting attended in person and (ii) $500 for each meeting attended telephonically, unless, in either case, such meeting is scheduled as an adjunct to a scheduled Board of Directors meeting for which the Directors are already being compensated.  Meeting fees will be paid quarterly in arrears.

 

Compensation for Members of the Compensation Committee of the Board

 

·           All Compensation Committee members other than the Chair of the committee will receive an annual cash fee of $2,500 (pro-rated based on the actual period served), to be paid quarterly in advance.

 

·           The Chair of the Compensation Committee shall receive an annual cash fee of $5,000 (pro-rated based on the actual period served), to be paid quarterly in advance.

 

·           All Compensation Committee members shall be reimbursed in cash for their expenses reasonably incurred in serving as Compensation Committee members and shall also be paid a cash fee of (i) $2,000 for each committee meeting attended in person and (ii) $500 for each meeting attended telephonically, unless, in either case, such meeting is scheduled as an adjunct to a scheduled Board of Directors meeting for which the Directors are already being compensated.  Meeting fees will be paid quarterly in arrears.

 

Compensation for Members of the Nominating and Corporate Governance

Committee of the Board

 

·           All Nominating and Corporate Governance Committee members other than the Chair of the committee will receive an annual cash fee of $2,500 (pro-rated based on the actual period served), to be paid quarterly in advance.

 

  

- 2 -

  

·           The Chair of the Nominating and Corporate Governance Committee shall receive an annual cash fee of $5,000 (pro-rated based on the actual period served), to be paid quarterly in advance.

 

·           All Nominating and Corporate Governance Committee members shall be reimbursed in cash for their expenses reasonably incurred in serving as Nominating and Corporate Governance Committee members and shall also be paid a cash fee of (i) $2,000 for each committee meeting attended in person and (ii) $500 for each meeting attended telephonically, unless, in either case, such meeting is scheduled as an adjunct to a scheduled Board of Directors meeting for which the Directors are already being compensated.  Meeting fees will be paid quarterly in arrears.

 

Other Compensation

 

·           Unless otherwise provided by the Compensation Committee or Board of Directors, all members (other than members who are also employees of the Company) of any other committees of the Board set up from time to time shall be reimbursed in cash for their expenses reasonably incurred in serving as members of such other committees of the Board and shall also be paid a cash fee of (i) $2,000 for each committee meeting attended in person and (ii) $500 for each meeting attended telephonically, unless, in either case, such meeting is scheduled as an adjunct to a scheduled Board of Directors meeting or other committee meeting for which the Directors are already being compensated.  Meeting fees will be paid quarterly in arrears.

 

·           In addition, the Compensation Committee or Board of Directors may from time to time compensate Directors for additional services performed at the request of the Board of Directors.

 

  

- 3 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00196-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00196-of-00352.parquet"}]]